Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread

被引:85
作者
Cheshenko, N
Keller, MJ
MasCasullo, V
Jarvis, GA
Cheng, H
John, M
Li, JH
Hogarty, K
Anderson, RA
Waller, DP
Zaneveld, LJD
Profy, AT
Klotman, ME
Herold, BC
机构
[1] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
[3] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[4] Rush Univ, Ctr Med, Dept Obstet & Gynecol, Chicago, IL 60612 USA
[5] Univ Illinois, Dept Pharmacol, Chicago, IL 60680 USA
[6] Indevus Pharmaceut Inc, Lexington, MA USA
关键词
D O I
10.1128/AAC.48.6.2025-2036.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Topical microbicides designed to prevent acquisition of sexually transmitted infections are urgently needed. Nonoxynol-9, the only commercially available spermicide, damages epithelium and may enhance human immunodeficiency virus transmission. The observation that herpes simplex virus (HSV) and human immunodeficiency virus bind heparan sulfate provided the rationale for the development of sulfated or sulfonated polymers as topical agents. Although several of the polymers have advanced to clinical trials, the spectrum and mechanism of anti-HSV activity and the effects on soluble mediators of inflammation have not been evaluated. The present studies address these gaps. The results indicate that PRO 2000, polystyrene sulfonate, cellulose sulfate, and polymethylenehydroquinone sulfonate inhibit HSV infection 10,000-fold and are active against clinical isolates, including an acyclovir-resistant variant. The compounds formed stable complexes with glycoprotein B and inhibit viral binding, entry, and cell-to-cell spread. The effects may be long lasting due to the high affinity and stability of the sulfated compound-virus complex, as evidenced by surface plasmon resonance studies. The candidate microbicides retained their antiviral activities in the presence of cervical secretions and over a broad pH range. There was little reduction in cell viability following repeated exposure of human endocervical cells to these compounds, although a reduction in secretory leukocyte protease inhibitor levels was observed. These studies support further development and rigorous evaluation of these candidate microbicides.
引用
收藏
页码:2025 / 2036
页数:12
相关论文
共 42 条
[1]   Study of the vaginal tolerance to acidform, an acid-buffering, bioadhesive gel [J].
Amaral, E ;
Faúndes, A ;
Zaneveld, L ;
Waller, D ;
Garg, S .
CONTRACEPTION, 1999, 60 (06) :361-366
[2]  
Anderson RA, 2000, J ANDROL, V21, P862
[3]  
Anderson RA, 2002, J ANDROL, V23, P426
[4]   The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model [J].
Bourne, N ;
Bernstein, DI ;
Ireland, J ;
Sonderfan, AJ ;
Profy, AT ;
Stanberry, LR .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01) :203-205
[5]   Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread [J].
Cheshenko, N ;
Herold, BC .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :2247-2255
[6]  
Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2
[7]   Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells [J].
Fichorova, RN ;
Anderson, DJ .
BIOLOGY OF REPRODUCTION, 1999, 60 (02) :508-514
[8]   The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission [J].
Fichorova, RN ;
Tucker, LD ;
Anderson, DJ .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (04) :418-428
[9]   MOLECULAR-BASIS OF LATENCY IN PATHOGENIC HUMAN VIRUSES [J].
GARCIABLANCO, MA ;
CULLEN, BR .
SCIENCE, 1991, 254 (5033) :815-820
[10]   Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM) [J].
Garg, S ;
Anderson, RA ;
Chany, CJ ;
Waller, DP ;
Diao, XH ;
Vermani, K ;
Zaneveld, LJD .
CONTRACEPTION, 2001, 64 (01) :67-75